Literature DB >> 25042745

Reply: To PMID 24084078.

Martin J Romeo1, Rachana Agrawal1, Anna Pomés2, Judith A Woodfolk3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25042745      PMCID： PMC4547453          DOI： 10.1016/j.jaci.2014.06.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

2.  Gene silencing and related oligonucleotide therapies for TH2-promoting cytokines.

Authors:  David H Dreyfus
Journal:  J Allergy Clin Immunol       Date:  2014-07-18       Impact factor: 10.793

3.  Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice.

Authors:  Yasemin Darcan-Nicolaisen; Holger Meinicke; Gabriele Fels; Olga Hegend; Annekathrin Haberland; Anja Kühl; Christoph Loddenkemper; Martin Witzenrath; Stefanie Kube; Wolfgang Henke; Eckard Hamelmann
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 4.  A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.

Authors:  Martin J Romeo; Rachana Agrawal; Anna Pomés; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

5.  Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice.

Authors:  Tricia N Lively; Karl Kossen; Annette Balhorn; Toshiyuki Koya; Shawn Zinnen; Katsuyuki Takeda; Joseph J Lucas; Barry Polisky; Ivan M Richards; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2007-10-22       Impact factor: 10.793
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.